» Articles » PMID: 20010815

Cdk2 Suppresses Cellular Senescence Induced by the C-myc Oncogene

Abstract

Activated oncogenes induce compensatory tumour-suppressive responses, such as cellular senescence or apoptosis, but the signals determining the main outcome remain to be fully understood. Here, we uncover a role for Cdk2 (cyclin-dependent kinase 2) in suppressing Myc-induced senescence. Short-term activation of Myc promoted cell-cycle progression in either wild-type or Cdk2 knockout mouse embryo fibroblasts (MEFs). In the knockout MEFs, however, the initial hyper-proliferative response was followed by cellular senescence. Loss of Cdk2 also caused sensitization to Myc-induced senescence in pancreatic beta-cells or splenic B-cells in vivo, correlating with delayed lymphoma onset in the latter. Cdk2-/- MEFs also senesced upon ectopic Wnt signalling or, without an oncogene, upon oxygen-induced culture shock. Myc also causes senescence in cells lacking the DNA repair protein Wrn. However, unlike loss of Wrn, loss of Cdk2 did not enhance Myc-induced replication stress, implying that these proteins suppress senescence through different routes. In MEFs, Myc-induced senescence was genetically dependent on the ARF-p53-p21Cip1 and p16INK4a-pRb pathways, p21Cip1 and p16INK4a being selectively induced in Cdk2-/- cells. Thus, although redundant for cell-cycle progression and development, Cdk2 has a unique role in suppressing oncogene- and/or stress-induced senescence. Pharmacological inhibition of Cdk2 induced Myc-dependent senescence in various cell types, including a p53-null human cancer cell line. Our data warrant re-assessment of Cdk2 as a therapeutic target in Myc- or Wnt-driven tumours.

Citing Articles

Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.

Ma B, Sang Y, Du X, Zhang Y, Yin M, Xu W Adv Sci (Weinh). 2024; 12(7):e2413514.

PMID: 39716890 PMC: 11831524. DOI: 10.1002/advs.202413514.


Transcriptomic analysis of cellular senescence induced by ectopic expression of ATF6α in human breast cancer cells.

Kim J, Bae S, Moon Y, Kim E, Kim Y, Park Y PLoS One. 2024; 19(10):e0309749.

PMID: 39466820 PMC: 11515977. DOI: 10.1371/journal.pone.0309749.


Combined Inhibition of and Reduce Cell Proliferation and Arrest Cell Cycle by Affecting in Pan-Cancer.

Liang K, Wang Q, Qiu L, Gong X, Chen Z, Zhang H Int J Mol Sci. 2023; 24(21).

PMID: 37958642 PMC: 10650476. DOI: 10.3390/ijms242115658.


NEK8 regulates colorectal cancer progression via phosphorylating MYC.

Cao B, Zhang K, Pan C, Dong Y, Lu F Cell Commun Signal. 2023; 21(1):209.

PMID: 37596667 PMC: 10436496. DOI: 10.1186/s12964-023-01215-z.


The SIRT1-c-Myc axis in regulation of stem cells.

Fan W, Li X Front Cell Dev Biol. 2023; 11:1236968.

PMID: 37554307 PMC: 10405831. DOI: 10.3389/fcell.2023.1236968.


References
1.
Adams J, Harris A, Pinkert C, Corcoran L, Alexander W, Cory S . The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985; 318(6046):533-8. DOI: 10.1038/318533a0. View

2.
Brooks E, Gray N, Joly A, Kerwar S, Lum R, Mackman R . CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem. 1997; 272(46):29207-11. DOI: 10.1074/jbc.272.46.29207. View

3.
Ortega S, Prieto I, Odajima J, Martin A, Dubus P, Sotillo R . Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat Genet. 2003; 35(1):25-31. DOI: 10.1038/ng1232. View

4.
Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B . Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 1996; 15(23):6595-604. PMC: 452484. View

5.
Krimpenfort P, Quon K, Mooi W, Loonstra A, Berns A . Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 2001; 413(6851):83-6. DOI: 10.1038/35092584. View